Hims & Hers Health (HIMS) Non-Current Assets (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Non-Current Assets came in at $1.2 billion in Q1 2026, up 174.69% year-on-year from $444.7 million in Q1 2025, and down 11.92% quarter-over-quarter from $1.4 billion in Q4 2025.
Hims & Hers Health (HIMS) Non-Current Assets (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Non-Current Assets across 8 years of filings, most recently posting $1.2 billion for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $1.2 billion, up 174.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 269.81% YoY), and the FY2025 annual result was $1.4 billion, up 344.99% from the prior year.
- Non-Current Assets came in at $1.2 billion for Q1 2026 at Hims & Hers Health, down from $1.4 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.4 billion in Q3 2025 to a low of $149.4 million in Q3 2022.
- The 5-year median for Non-Current Assets is $186.4 million (2024), against an average of $421.9 million.
- Peak annual rise in Non-Current Assets reached 2531.36% in 2022, while the deepest fall reached 0.62% in 2022.
- Hims & Hers Health's Non-Current Assets stood at $149.7 million in 2022, then rose by 17.62% to $176.1 million in 2023, then soared by 76.97% to $311.7 million in 2024, then jumped by 344.99% to $1.4 billion in 2025, then declined by 11.92% to $1.2 billion in 2026.
- The last three Non-Current Assets figures came in at $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 68.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.22 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.39 Bn |
| Jun 30, 2025 | 522.02 Mn |
| Mar 31, 2025 | 444.75 Mn |
| Dec 31, 2024 | 311.71 Mn |
| Sep 30, 2024 | 275.89 Mn |
| Jun 30, 2024 | 189.58 Mn |
| Mar 31, 2024 | 186.37 Mn |
| Dec 31, 2023 | 176.13 Mn |
| Sep 30, 2023 | 163.65 Mn |
| Jun 30, 2023 | 155.24 Mn |
| Mar 31, 2023 | 150.78 Mn |
| Dec 31, 2022 | 149.75 Mn |
| Sep 30, 2022 | 149.37 Mn |
| Jun 30, 2022 | 149.48 Mn |
| Mar 31, 2022 | 150.09 Mn |
| Dec 31, 2021 | 150.68 Mn |
| Sep 30, 2021 | 145.84 Mn |
| Jun 30, 2021 | 11.36 Mn |